These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 33117115)

  • 21. Imaging Kappa Opioid Receptors in the Living Brain with Positron Emission Tomography.
    Placzek MS
    Handb Exp Pharmacol; 2022; 271():547-577. PubMed ID: 34363128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of a novel radiotracer for positron emission tomography imaging of reactive oxygen species in the central nervous system.
    Wilson AA; Sadovski O; Nobrega JN; Raymond RJ; Bambico FR; Nashed MG; Garcia A; Bloomfield PM; Houle S; Mizrahi R; Tong J
    Nucl Med Biol; 2017 Oct; 53():14-20. PubMed ID: 28719807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nuclear imaging approaches facilitating nanomedicine translation.
    Pérez-Medina C; Teunissen AJP; Kluza E; Mulder WJM; van der Meel R
    Adv Drug Deliv Rev; 2020; 154-155():123-141. PubMed ID: 32721459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of (18)F-labeled radiotracers for neuroreceptor imaging with positron emission tomography.
    Brust P; van den Hoff J; Steinbach J
    Neurosci Bull; 2014 Oct; 30(5):777-811. PubMed ID: 25172118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advances in [
    Francis F; Wuest F
    Molecules; 2021 Oct; 26(21):. PubMed ID: 34770885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strategies for designing novel positron emission tomography (PET) radiotracers to cross the blood-brain barrier.
    Lindberg A; Chassé M; Varlow C; Pees A; Vasdev N
    J Labelled Comp Radiopharm; 2023 Jul; 66(9):205-221. PubMed ID: 36815704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Applications of neuroreceptor imaging to psychiatry research.
    Smith GS; Koppel J; Goldberg S
    Psychopharmacol Bull; 2003; 37(4):26-65. PubMed ID: 15131516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ready for prime time? Dual tracer PET and SPECT imaging.
    Fakhri GE
    Am J Nucl Med Mol Imaging; 2012; 2(4):415-7. PubMed ID: 23145358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Real-Time Microfluidic Blood-Counting System for PET and SPECT Preclinical Pharmacokinetic Studies.
    Convert L; Lebel R; Gascon S; Fontaine R; Pratte JF; Charette P; Aimez V; Lecomte R
    J Nucl Med; 2016 Sep; 57(9):1460-6. PubMed ID: 27151983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent Advances in Targeting Nuclear Molecular Imaging Driven by Tetrazine Bioorthogonal Chemistry.
    Dong P; Wang X; Zheng J; Zhang X; Li Y; Wu H; Li L
    Curr Med Chem; 2020; 27(23):3924-3943. PubMed ID: 31267851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Challenges for Developing PET Tracers: Isotopes, Chemistry, and Regulatory Aspects.
    Mach RH; Schwarz SW
    PET Clin; 2010 Apr; 5(2):131-53. PubMed ID: 27157669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PET radiotracers for molecular imaging in the brain: past, present and future.
    Zimmer L; Luxen A
    Neuroimage; 2012 Jun; 61(2):363-70. PubMed ID: 22222719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [PET imaging for better understanding of normal and pathological neurotransmission].
    Zimmer L
    Biol Aujourdhui; 2019; 213(3-4):109-120. PubMed ID: 31829931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiolabeled multimeric cyclic RGD peptides as integrin alphavbeta3 targeted radiotracers for tumor imaging.
    Liu S
    Mol Pharm; 2006; 3(5):472-87. PubMed ID: 17009846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nicotinic acetylcholine receptors and imaging.
    Gündisch D
    Curr Pharm Des; 2000 Jul; 6(11):1143-57. PubMed ID: 10903387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New SPECT and PET radiopharmaceuticals for imaging cardiovascular disease.
    Sogbein OO; Pelletier-Galarneau M; Schindler TH; Wei L; Wells RG; Ruddy TD
    Biomed Res Int; 2014; 2014():942960. PubMed ID: 24901002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identifying novel radiotracers for PET imaging of the brain: application of LC-MS/MS to tracer identification.
    Barth V; Need A
    ACS Chem Neurosci; 2014 Dec; 5(12):1148-53. PubMed ID: 24828747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiotracers for imaging of Parkinson's disease.
    Abbasi Gharibkandi N; Hosseinimehr SJ
    Eur J Med Chem; 2019 Mar; 166():75-89. PubMed ID: 30685535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advanced Methods for Radiolabeling Multimodality Nanomedicines for SPECT/MRI and PET/MRI.
    Lamb J; Holland JP
    J Nucl Med; 2018 Mar; 59(3):382-389. PubMed ID: 29025988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.